10-15 Associates’s Adient ADNT Stock Holding History

10-15 Associates’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,827	Closed	-$868K	–	102
2016 Q4	$868K	Buy	+14,827	New	+$783K	0.24%	67

Other funds holding ADNT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

KCM

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

10-15 Associates's ADNT Position: Q1 2017 in Review

10-15 Associates sold out of Adient (ADNT) in Q1 2017, closing a stake of 14,827 shares — an estimated $868K sold.

10-15 Associates first reported a position in ADNT in Q4 2016 and held it in 1 quarter. The position peaked at $868K in Q4 2016. 452 funds tracked by Wall St. Rank hold ADNT as of Q1 2017.

10-15 Associates reported no remaining Adient position as of Q1 2017 after selling out during the quarter.
10-15 Associates sold 14,827 Adient shares in Q1 2017, an estimated $868K.
10-15 Associates first reported a position in Adient in Q4 2016 and held it in 1 quarter.
10-15 Associates's Adient position peaked at $868K in Q4 2016.
452 funds tracked by Wall St. Rank held Adient as of Q1 2017.

Based on 10-15 Associates's 13F filing for Q1 2017, filed 16 May 2017.